StockData
Rani Therapeutics Holdings, Inc. logo

Rani Therapeutics Holdings, Inc. (RANI) stock

RANINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 3/3043% above fair value
$0.56+0.02 (+3.54%)

Close on Nov 17, 2026Market cap $77.98MP/E –Yield –

Rani Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for Rani Therapeutics

Rani Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Rani Therapeutics figures

See a number that looks wrong?